MED-EL hearing implants are the result of an innovative
research tradition spanning the past thirty years. Since its founders
developed one of the world’s first cochlear implants in
1975, MED-EL has set new standards in hearing implant technologies,
developing and manufacturing technologically advanced hearing
solutions for people with varying degrees of hearing loss. MED-EL
hearing implant systems, currently used by children and adults
in 70 countries worldwide, combine the latest scientific advancements
and pioneering engineering and manufacturing techniques for performance,
safety and reliability. Especially important for infants and children
(65% of MED-EL CI recipients are children), MED-EL implant systems
are designed to be future ready, offering unparalleled performance
today while preserving options for future upgrades and technological
developments.
2004
MED-EL launches the PULSARci implant, redefining the
limits of cochlear implants.
MED-EL becomes the world’s leading company in hearing
implants with the acquisition of the Vibrant Soundbridge,
the first implantable middle ear hearing device for mild
to severe sensorineural hearing loss.
2003
MED-EL receives FDA approval for use
with Magnetic Resonance Imaging (MRI) at 0.2T.
MED-EL receives FDA approval for implantation in children
12 months of age and older.
2002
MED-EL receives FDA approval
for CI.STUDIO+ software package and use of Remote Consultative
Services.
MED-EL receives FDA approval for both the COMBI 40+ GB (split)
and COMBI 40+ S (compressed) systems, with specialized electrode
arrays for difficult surgical cases.
2001
MED-EL receives
FDA approval for use of the COMBI 40+ Cochlear Implant System
in both adults and children.
1999
The TEMPO+ BTE speech processor
is launched, combining a comfortable design and the latest
sophisticated technology for improved speech signal processing.
1996
Worldwide introduction of the
COMBI 40+ Implant, the thinnest implant available, an essential
factor for very young children.
The first MED-EL patient implanted bilaterally with two
COMBI 40 Implants.
1995
First implantation of the COMBI
40H in the United States.
MED-EL CIS LINK system introduced to provide high-rate CIS
stimulation for users of the Ineraid cochlear implant.
1994
The COMBI 40 system introduced
internationally as the world's first high-speed multi-channel
cochlear implant.
1991
Further development of the COMFORT
device results in the world's first behind-the-ear (BTE)
speech processor.
1989
MED-EL founded.
International introduction of the COMFORT cochlear implant.
1977
The world's first hybrid multi-channel
cochlear implant, developed by MED-EL’s founders,
is implanted in Vienna, Austria.
1975
First implant developments started
by the founders of MED-EL, Ingeborg and Erwin Hochmair.
Upcoming
Workshops
